Moneycontrol PRO
HomeNewsBalajiamines
Jump to
  • Accumulate Balaji Amines; target of Rs 1612: Deven Choksey

    Deven Choksey recommended accumulate rating on Balaji Amines with a target price of Rs 1612 in its research report dated June 10, 2025.

  • Accumulate Balaji Amines; target of Rs 1640: KR Choksey

    Accumulate Balaji Amines; target of Rs 1640: KR Choksey

    KR Choksey recommended accumulate rating on Balaji Amines with a target price of Rs 1640 in its research report dated February 14, 2025.

  • Buy Balaji Amines; target of Rs 2,569: KR Choksey

    Buy Balaji Amines; target of Rs 2,569: KR Choksey

    KR Choksey is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 2,569 in its research report dated August 09, 2024.

  • Buy Balaji Amines; target of Rs 2653: CD Equisearch

    Buy Balaji Amines; target of Rs 2653: CD Equisearch

    CD Equisearch is bullish on Balaji Amines recommended buy rating on the stock with a target price of Rs 2653 in its research report dated March 20, 2024.

  • Buy Balaji Amines; target of Rs 3191: KR Choksey

    Buy Balaji Amines; target of Rs 3191: KR Choksey

    KR Choksey is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 3191 in its research report dated May 25, 2023.

  • Balaji Amines: Does it merit a look?

    Balaji Amines: Does it merit a look?

    Key monitorable to watch would be sustenance of operating margins for the subsidiary - Balaji Specialty

  • Buy Balaji Amines; target of Rs 3790: KR Choksey

    Buy Balaji Amines; target of Rs 3790: KR Choksey

    KR Choksey is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 3790 in its research report dated February 13, 2023.

  • Is there an opportunity to invest in the chemical sector?

    Is there an opportunity to invest in the chemical sector?

    Valuations for the sector are, by and large, not expensive but not cheap either. In some cases, it is close to the long-term averages and should be evaluated case by case.

  • European energy crisis: Gains and pains for Indian chemical players

    European energy crisis: Gains and pains for Indian chemical players

    Force majeure in European Chemicals industry can lead to significant shortfall in range of chemicals

  • Balaji Amines: Spot the value unlocking chemistry

    Balaji Amines: Spot the value unlocking chemistry

    In the domestic market, growth visibility for the subsidiary comes from capacity expansion plans of the company’s key clients – Indofil, UPL and Aarti industries

  • Balaji Amines: An eagle eye for import substitution opportunities

    Balaji Amines: An eagle eye for import substitution opportunities

    Balaji Amine’s project execution is worth noticing, due to which earnings potential has significantly increased over the years

  • Buy Balaji Amines; target of Rs 5674: KR Choksey

    Buy Balaji Amines; target of Rs 5674: KR Choksey

    KR Choksey is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 5674 in its research report dated February 04, 2022.

  • For chemicals, Budget 2022 is a minor reversal of import substitution policy

    For chemicals, Budget 2022 is a minor reversal of import substitution policy

    A reduction of duties on key chemicals to help soften raw material inflation

  • Balaji Amines: Agile execution of import substitution play

    Balaji Amines: Agile execution of import substitution play

    We remain positive on Balaji’s strategy to focus on import substitution opportunities. In the process, the management appears nimble in implementing change in technology, process and products to edge out global competition

  • Buy Balaji Amines; target of Rs 3613: CD Equisearch

    Buy Balaji Amines; target of Rs 3613: CD Equisearch

    CD Equisearch is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 3613 in its research report dated June 28, 2021.

  • Balaji Amines: Take some profit off the table?

    Balaji Amines: Take some profit off the table?

    Coming to near-term prospects, next year, Balaji Amines should benefit from additional volume from higher capacity, helped by firm demand in the pharma end-market

  • Balaji Amines Q2: Import substitution play gets better with uplift in pharma

    Balaji Amines Q2: Import substitution play gets better with uplift in pharma

    The new capex announcement for amine raw materials bridges a growing gap for Balaji Amines

  • Buy Balaji Amines; target of Rs 1104: CD Equisearch

    Buy Balaji Amines; target of Rs 1104: CD Equisearch

    CD Equisearch is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 1104 in its research report dated August 31, 2020.

  • Balaji Amines —  Time to book profit

    Balaji Amines — Time to book profit

    Balaji Amines' operating margins take on shine on the back of softening raw material prices and a better product mix

  • Buy Balaji Amines; target of Rs 560: HDFC Securities

    Buy Balaji Amines; target of Rs 560: HDFC Securities

    HDFC Securities is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 560 in its research report dated June 24, 2020.

  • Speciality Chemicals: Do current valuations present an opportunity?

    Speciality Chemicals: Do current valuations present an opportunity?

  • Balaji Amines: Anti-dumping probe is just what the doctor ordered

    Balaji Amines: Anti-dumping probe is just what the doctor ordered

  • Balaji Amines: Green clearance sets up the right pitch

    Balaji Amines: Green clearance sets up the right pitch

  • Balaji Amines Q2: Strong uptick in volumes to aid rerating

    Balaji Amines Q2: Strong uptick in volumes to aid rerating

  • Ranitidine controversy: Which Indian pharma companies stand to lose?

    Ranitidine controversy: Which Indian pharma companies stand to lose?

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347